| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:36 UTC |
|---|
| HMDB ID | HMDB0014408 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Sulfisoxazole |
|---|
| Description | Sulfisoxazole is only found in individuals that have used or taken this drug. It is a short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms. [PubChem]Sulfisoxazole is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. |
|---|
| Structure | CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C InChI=1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 3,4-Dimethyl-5-sulfanilamidoisoxazole | ChEBI | | 3,4-Dimethyl-5-sulfonamidoisoxazole | ChEBI | | 3,4-Dimethyl-5-sulphanilamidoisoxazole | ChEBI | | 3,4-Dimethyl-5-sulphonamidoisoxazole | ChEBI | | 3,4-Dimethylisoxazole-5-sulfanilamide | ChEBI | | 3,4-Dimethylisoxazole-5-sulphanilamide | ChEBI | | 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide | ChEBI | | 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide | ChEBI | | 5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole | ChEBI | | 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisoxazole | ChEBI | | 5-(p-Aminobenzenesulphonamido)-3,4-dimethylisoxazole | ChEBI | | 5-Sulfanilamido-3,4-dimethylisoxazole | ChEBI | | 5-Sulphanilamido-3,4-dimethyl-isoxazole | ChEBI | | N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide | ChEBI | | N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide | ChEBI | | N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide | ChEBI | | Sulfadimethylisoxazole | ChEBI | | Sulfafurazol | ChEBI | | Sulfafurazole | ChEBI | | Sulfafurazolum | ChEBI | | Sulfaisoxazole | ChEBI | | Sulfasoxazole | ChEBI | | Sulfisonazole | ChEBI | | Sulfisoxasole | ChEBI | | Sulfisoxazol | ChEBI | | Sulfofurazole | ChEBI | | Sulphadimethylisoxazole | ChEBI | | Sulphafurazol | ChEBI | | Sulphafurazole | ChEBI | | Sulphaisoxazole | ChEBI | | Sulphisoxazol | ChEBI | | Sulphofurazole | ChEBI | | Gantrisin | Kegg | | 5-(4-Aminophenylsulphonamido)-3,4-dimethylisoxazole | Generator | | 5-Sulphanilamido-3,4-dimethylisoxazole | Generator | | 5-Sulfanilamido-3,4-dimethyl-isoxazole | Generator | | N'-(3,4)dimethylisoxazol-5-yl-sulfanilamide | Generator | | Sulphafurazolum | Generator | | Sulphasoxazole | Generator | | Sulphisonazole | Generator | | Sulphisoxasole | Generator | | Sulphisoxazole | Generator | | Sulfisoxazole dialamine | HMDB | | Sulfisoxazole diolamine | HMDB | | Ammonium salt sulfisoxazole | HMDB | | Diolamine, sulfisoxazole | HMDB | | Roche brand OF sulfisoxazole | HMDB | | Sulfasoxizole | HMDB | | Sulfisoxazole roche brand | HMDB | | Sulfisoxazole, monosodium salt | HMDB | | TL-Azole | HMDB | | V-Sul | HMDB | | Pediatric, gantrisin | HMDB | | Sulfisoxazole, ammonium salt | HMDB | | Sulfisoxazole, monolithium salt | HMDB | | TL Azole | HMDB | | V Sul | HMDB | | Gantrisin pediatric | HMDB | | Monolithium salt sulfisoxazole | HMDB | | Sulfisoxazole, monosodium, monomesylate salt | HMDB | | Vangard brand OF sulfisoxazole | HMDB | | FNA brand OF sulfisoxazole | HMDB | | Monosodium salt sulfisoxazole | HMDB | | Neoxazoi | HMDB | | Roche brand OF sulfisoxazole acetate | HMDB | | Roche brand OF sulfisoxazole diolamine | HMDB | | Sulfadimethyloxazole | HMDB | | Sulfafurazol fna | HMDB | | Sulfisoxazole, triammonium salt | HMDB | | Triammonium salt sulfisoxazole | HMDB | | Zenith brand OF sulfisoxazole | HMDB |
|
|---|
| Chemical Formula | C11H13N3O3S |
|---|
| Average Molecular Weight | 267.304 |
|---|
| Monoisotopic Molecular Weight | 267.067761987 |
|---|
| IUPAC Name | 4-amino-N-(dimethyl-1,2-oxazol-5-yl)benzene-1-sulfonamide |
|---|
| Traditional Name | ganda |
|---|
| CAS Registry Number | 127-69-5 |
|---|
| SMILES | CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C |
|---|
| InChI Identifier | InChI=1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3 |
|---|
| InChI Key | NHUHCSRWZMLRLA-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzenesulfonamides |
|---|
| Direct Parent | Aminobenzenesulfonamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminobenzenesulfonamide
- Benzenesulfonyl group
- Aniline or substituted anilines
- Organosulfonic acid amide
- Azole
- Isoxazole
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Aminosulfonyl compound
- Heteroaromatic compound
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Organonitrogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Amine
- Primary amine
- Organosulfur compound
- Organopnictogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 194 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.31 g/L | Not Available | | LogP | 0.9 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.65 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.2901 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.35 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1068.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 250.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 100.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 160.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 48.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 261.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 425.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 95.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 761.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 243.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 985.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 225.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 304.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 342.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 246.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 195.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Sulfisoxazole,1TMS,isomer #1 | CC1=NOC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=C1C | 2793.8 | Semi standard non polar | 33892256 | | Sulfisoxazole,1TMS,isomer #1 | CC1=NOC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=C1C | 2501.5 | Standard non polar | 33892256 | | Sulfisoxazole,1TMS,isomer #1 | CC1=NOC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=C1C | 3742.4 | Standard polar | 33892256 | | Sulfisoxazole,1TMS,isomer #2 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=C1C | 2568.7 | Semi standard non polar | 33892256 | | Sulfisoxazole,1TMS,isomer #2 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=C1C | 2428.0 | Standard non polar | 33892256 | | Sulfisoxazole,1TMS,isomer #2 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=C1C | 3702.1 | Standard polar | 33892256 | | Sulfisoxazole,2TMS,isomer #1 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=C1C | 2616.7 | Semi standard non polar | 33892256 | | Sulfisoxazole,2TMS,isomer #1 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=C1C | 2571.7 | Standard non polar | 33892256 | | Sulfisoxazole,2TMS,isomer #1 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=C1C | 3155.0 | Standard polar | 33892256 | | Sulfisoxazole,2TMS,isomer #2 | CC1=NOC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=C1C | 2666.3 | Semi standard non polar | 33892256 | | Sulfisoxazole,2TMS,isomer #2 | CC1=NOC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=C1C | 2611.2 | Standard non polar | 33892256 | | Sulfisoxazole,2TMS,isomer #2 | CC1=NOC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=C1C | 3479.8 | Standard polar | 33892256 | | Sulfisoxazole,3TMS,isomer #1 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=C1C | 2568.7 | Semi standard non polar | 33892256 | | Sulfisoxazole,3TMS,isomer #1 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=C1C | 2719.4 | Standard non polar | 33892256 | | Sulfisoxazole,3TMS,isomer #1 | CC1=NOC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=C1C | 2989.2 | Standard polar | 33892256 | | Sulfisoxazole,1TBDMS,isomer #1 | CC1=NOC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3047.2 | Semi standard non polar | 33892256 | | Sulfisoxazole,1TBDMS,isomer #1 | CC1=NOC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=C1C | 2724.8 | Standard non polar | 33892256 | | Sulfisoxazole,1TBDMS,isomer #1 | CC1=NOC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3731.6 | Standard polar | 33892256 | | Sulfisoxazole,1TBDMS,isomer #2 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=C1C | 2860.1 | Semi standard non polar | 33892256 | | Sulfisoxazole,1TBDMS,isomer #2 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=C1C | 2652.4 | Standard non polar | 33892256 | | Sulfisoxazole,1TBDMS,isomer #2 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=C1C | 3675.5 | Standard polar | 33892256 | | Sulfisoxazole,2TBDMS,isomer #1 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3145.8 | Semi standard non polar | 33892256 | | Sulfisoxazole,2TBDMS,isomer #1 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3035.0 | Standard non polar | 33892256 | | Sulfisoxazole,2TBDMS,isomer #1 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3248.2 | Standard polar | 33892256 | | Sulfisoxazole,2TBDMS,isomer #2 | CC1=NOC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3212.2 | Semi standard non polar | 33892256 | | Sulfisoxazole,2TBDMS,isomer #2 | CC1=NOC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3042.1 | Standard non polar | 33892256 | | Sulfisoxazole,2TBDMS,isomer #2 | CC1=NOC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3497.1 | Standard polar | 33892256 | | Sulfisoxazole,3TBDMS,isomer #1 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3322.7 | Semi standard non polar | 33892256 | | Sulfisoxazole,3TBDMS,isomer #1 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3418.2 | Standard non polar | 33892256 | | Sulfisoxazole,3TBDMS,isomer #1 | CC1=NOC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=C1C | 3173.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Sulfisoxazole GC-MS (Non-derivatized) - 70eV, Positive | splash10-0900-9730000000-37990b4248c5baa9e04d | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Sulfisoxazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole LC-ESI-qTof , Positive-QTOF | splash10-0a4i-5911100000-18e92b64e6fb25ed4e6d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole LC-ESI-QTOF , positive-QTOF | splash10-0a4i-3900000000-23eed4bc89bcf24079bd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole , positive-QTOF | splash10-0aor-1930000000-47a2d9042541d8f86f85 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole , positive-QTOF | splash10-0a4i-2930000000-9fc0d3e8e143637637e8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole , positive-QTOF | splash10-0a4i-5911100000-18e92b64e6fb25ed4e6d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 30V, Positive-QTOF | splash10-00dr-0950000000-f72ff7fcf12328285baa | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 90V, Negative-QTOF | splash10-03fr-9100000000-f9b4074ff0dbce87a4f1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 75V, Negative-QTOF | splash10-08i0-9400000000-2ee13954a7c301283cde | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 45V, Negative-QTOF | splash10-00di-1920000000-5c4914f2b37d11a0b20d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 90V, Positive-QTOF | splash10-03fr-9100000000-1fbacdbcfcd2419945ab | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 60V, Positive-QTOF | splash10-05fr-5900000000-1f2cdce7f1727b5849cb | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 60V, Negative-QTOF | splash10-05fr-5900000000-8f3543901af074ef0b8c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 45V, Positive-QTOF | splash10-00di-1920000000-1c6ddf7859a7d4c57dc7 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 30V, Negative-QTOF | splash10-00dr-0950000000-e80c5daa56061b891587 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 15V, Negative-QTOF | splash10-014i-0390000000-7a0e174c86b909bba0c7 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 75V, Positive-QTOF | splash10-0aou-9700000000-fe3300abd7bed628067c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 90V, Positive-QTOF | splash10-066r-9400000000-92ddd6dff24e64160967 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 30V, Positive-QTOF | splash10-0a4i-0900000000-9cea617b589f13ee970f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfisoxazole 15V, Positive-QTOF | splash10-0a4i-0920000000-e05fbd5cf080af27accf | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfisoxazole 10V, Positive-QTOF | splash10-0gb9-0190000000-67fdd03c85b2a068b40a | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfisoxazole 20V, Positive-QTOF | splash10-0uxr-2390000000-541f0c03f60a901170c5 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfisoxazole 40V, Positive-QTOF | splash10-0uyi-9010000000-ed61e7aa315127ee534d | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfisoxazole 10V, Negative-QTOF | splash10-014i-0090000000-3fea2cb8533f6dac809a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfisoxazole 20V, Negative-QTOF | splash10-014i-9360000000-9a2a000e0d0fc02729a6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfisoxazole 40V, Negative-QTOF | splash10-0a4l-9800000000-4c399debcac1dfd41d87 | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|